R&D News | pharmaphorum

News

AstraZeneca and Daiichi Sankyo's Enhertu has been shown to provide a benefit in a phase 3 trial in early-stage breast cancer for the first time.

News

An AI model is being piloted at a national scale for the first time, but will it be able to predict future health risks reliably?

News

Eli Lilly has added another candidate to a growing pipeline of therapies for ALS, tapping Alchemab for an antibody sourced from 'resilient' patients.

News

The EU has announced a €500m scheme to convince scientific talent from around the world to relocate to Europe's "free and open" research environment.

News

In a potentially pivotal trial, PTC Therapeutics' therapy for Huntington's disease met its primary endpoint, but there are questions about the data.

News

The UK is said to be preparing a £50m scheme to attract top scientific talent from other countries, including US teams facing big funding cuts.